Sees FY25 revenue $16.8B-$17.2B, consensus $17.24B
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TEVA:
- Teva, Alvotech: FDA approves interchangeability for SELARSDI with Stelara
- Teva, Alvotech announce FDA approval of interchangeability for SELARSDI
- Teva Pharmaceutical Industries Limited (TEVA) Q1 Earnings Cheat Sheet
- Teva price target lowered to $20 from $24 at HSBC
- Teva Pharmaceutical’s Strategic Focus on EBITDA Growth and Cost Efficiencies Drives Buy Rating
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue